AA
RNAM

AQR Arbitrage’s Avidity Biosciences RNAM Stock Holding History

AQR Arbitrage’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-208,705
Closed -$15.1M – 602
2025
Q4 		$15.1M Buy
+208,705
New +$13.5M 0.32% 82

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

AQR Arbitrage's RNAM Position: Q1 2026 in Review

AQR Arbitrage sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 208,705 shares — an estimated $15.1M sold.

AQR Arbitrage first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $15.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • AQR Arbitrage reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • AQR Arbitrage sold 208,705 Avidity Biosciences shares in Q1 2026, an estimated $15.1M.
  • AQR Arbitrage first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • AQR Arbitrage's Avidity Biosciences position peaked at $15.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.